WallStSmart

Medtronic PLC (MDT)vsNortech Systems Incorporated (NSYS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 30018% more annual revenue ($37.54B vs $124.65M). MDT leads profitability with a 13.9% profit margin vs 0.8%. MDT trades at a lower P/E of 22.6x. MDT earns a higher WallStSmart Score of 68/100 (B-).

MDT

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 5.3Quality: 6.5
Piotroski: 5/9Altman Z: 1.99

NSYS

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 4.7Quality: 6.5
Piotroski: 3/9Altman Z: 3.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTUndervalued (+3.7%)

Margin of Safety

+3.7%

Fair Value

$94.43

Current Price

$90.96

$3.47 discount

UndervaluedFair: $94.43Overvalued

Intrinsic value data unavailable for NSYS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$116.35B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EPS GrowthGrowth
40.7%8/10

Earnings expanding 40.7% YoY

Free Cash FlowQuality
$1.29B8/10

Generating 1.3B in free cash flow

NSYS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
3.0210/10

Safe zone — low bankruptcy risk

Areas to Watch

MDT2 concerns · Avg: 4.0/10
PEG RatioValuation
1.654/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

NSYS4 concerns · Avg: 3.3/10
P/E RatioValuation
32.5x4/10

Premium valuation, high expectations priced in

Market CapQuality
$33.42M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

Profit MarginProfitability
0.8%3/10

0.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, EPS Growth. Revenue growth of 13.7% demonstrates continued momentum.

Bull Case : NSYS

The strongest argument for NSYS centers on Price/Book, Altman Z-Score.

Bear Case : MDT

The primary concerns for MDT are PEG Ratio, Altman Z-Score.

Bear Case : NSYS

The primary concerns for NSYS are P/E Ratio, Market Cap, Return on Equity. Thin 0.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

MDT carries more volatility with a beta of 0.57 — expect wider price swings.

MDT is growing revenue faster at 13.7% — sustainability is the question.

MDT generates stronger free cash flow (1.3B), providing more financial flexibility.

Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDT scores higher overall (68/100 vs 37/100) and 13.7% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Nortech Systems Incorporated

HEALTHCARE · MEDICAL DEVICES · USA

Nortech Systems Incorporated is an electronic manufacturing services company in the United States, Mexico, and China. The company is headquartered in Maple Grove, Minnesota.

Visit Website →

Want to dig deeper into these stocks?